Beta-adrenergic blocking agents: their current status.
Use of beta (beta)-adrenergic blocking agents began in the 1960s and has risen dramatically since then. Newer agents offer more actions and fewer side effects. Uses for the drugs continue to increase as their safety and efficacy become increasingly apparent. beta block, today, has widespread application in cardiovascular disease. In addition, these agents are used in the management of endocrine disorders, neurologic situations, psychiatric disorders, gastrointestinal problems, and sensory disorders. Many new beta blockers are still investigational, and some show even greater promise for therapeutic applications in the future.
B K
BK
Clark
D000319:Adrenergic beta-Antagonists / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D000328:Adult; D000368:Aged; D000375:Aging / Q000502:physiology; D002318:Cardiovascular Diseases / Q000188:drug therapy*; D002648:Child; D004700:Endocrine System Diseases / Q000188:drug therapy; D006801:Humans; D001523:Mental Disorders / Q000188:drug therapy; D008881:Migraine Disorders / Q000188:drug therapy; D009422:Nervous System Diseases / Q000188:drug therapy; D044469:Racial Groups
D000319:Adrenergic beta-Antagonists